4-(氯甲基)-2-苯基-1,3-噻唑 | 4771-31-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 4-(氯甲基)-2-苯基-1,3-噻唑
• 中文别名: 4-氯甲基-2-苯基-噻唑；2-苯基-4-氯甲基噻唑
• 英文名称: 2-phenyl-4-chloromethylthiazole
• 英文别名: 4-chloromethyl-2-phenylthiazole；4-(chloromethyl)-2-phenyl-1,3-thiazole；2-Phenyl-4-chlormethyl-thiazol；2-phenyl-4-thiazolylmethyl chloride
• CAS: 4771-31-7
• 化学式: C₁₀H₈ClNS
• mdl: MFCD00723503
• 分子量: 209.699
• InChiKey: SVEGSFSFMLCNFF-UHFFFAOYSA-N

物化性质

• 熔点：
  49 °C
• 沸点：
  155-156 °C
• 密度：
  1.270±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  41.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  C
• 安全说明：
  S45
• 危险类别码：
  R34
• 海关编码：
  2934100090
• 危险品运输编号：
  UN 3261
• 储存条件：
  存储条件：2-8℃，干燥且密封。

SDS

Name:	4-(Chloromethyl)-2-phenyl-1 3-thiazole 97% Material Safety Data Sheet
Synonym:
CAS:	4771-31-7

Section 1 - Chemical Product MSDS Name:4-(Chloromethyl)-2-phenyl-1 3-thiazole 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
4771-31-7	4-(Chloromethyl)-2-phenyl-1,3-thiazole	97%	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 4771-31-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 48 - 51 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H8ClNS
Molecular Weight: 210

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Bases, amines, oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4771-31-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-(Chloromethyl)-2-phenyl-1,3-thiazole - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 4771-31-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 4771-31-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4771-31-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(氯甲基)-2-苯基-1,3-噻唑 在 potassium carbonate 、 potassium hydroxide 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.0h， 生成 3-(4-((2-phenylthiazol-4-yl)methoxy)phenyl)-1-(p-tolyl)prop-2-en-1-one
  参考文献：
  名称：

  An Efficient Synthesis of New Pyrazolines and Isoxazolines Bearing Thiazolyl and Etheral Pharmacophores

  摘要：

  以 2-苯基-4-氯甲基噻唑（1）为起点，开发出了一条简便的合成路线，用于合成 5-(4-((2-苯基噻唑-4-基)甲氧基)苯基)-3-(4-取代苯基)吡唑啉类化合物（5a-f）和 5-(4-((2-苯基噻唑-4-基)甲氧基)苯基)-3-(4-取代苯基)异恶唑类化合物（6a-f）。氯甲基噻唑（1）首先与 4-羟基苯甲醛（2）缩合，得到 4-((2-苯基噻唑-4-基)甲氧基)苯甲醛（3）。4-((2- 苯基噻唑-4-基)甲氧基)苯甲醛 (3) 与苯乙酮在碱性醇中进行 Claisen-Smidth 缩合，得到 3-(4-((2-苯基噻唑-4-基)甲氧基)苯基)-1-(4-取代苯基)丙-2-烯-1-酮 (4a-f)。在胶束十四烷基三甲基溴化铵（TTAB）水介质中，2-丙烯-1-酮首次分别与水合肼和盐酸羟胺进行了环缩合反应，从而以良好至极佳的收率得到了标题杂环。

  DOI：

  10.5012/bkcs.2012.33.6.2012
• 作为产物：
  描述：

  硫代苯甲酰胺 在 氯化亚砜 、 碳酸氢钠 作用下， 以 1,4-二氧六环 为溶剂， 反应 120.5h， 生成 4-(氯甲基)-2-苯基-1,3-噻唑
  参考文献：
  名称：

  4-氯甲基噻唑的改良合成

  摘要：

  据报道由硫代酰胺和1，3-二氯丙酮进行的2-取代的4-氯甲基噻唑的两次反应合成。第一步，在非质子溶剂中在碳​​酸氢盐存在下，进行环化成2-取代的4-氯甲基-4-羟基噻唑啉。该中间体脱水成2-取代的4-氯甲基噻唑是通过与亚硫酰氯，硫酰氯，磷酰氯，三氯化磷或五氯化磷反应而完成的。硫代酰胺上的取代基，例如氨基，烷基或芳基，显示不影响反应的成功。作为趋势，烷基硫代酰胺比芳基硫代酰胺的4-氯甲基噻唑产率更高。使用该方法制备的4-氯甲基噻唑的产率与使用酸催化方法获得的产率相当。

  DOI：

  10.1002/jhet.5570230253

文献信息

• Design, synthesis, and bioactivities of novel pyridazinone derivatives containing <scp>2‐phenylthiazole</scp> or oxazole skeletons
  作者：Mingming Dang、Minhua Liu、Lu Huang、Xiaoming Ou、Chuyun Long、Xingping Liu、Yeguo Ren、Ping Zhang、Mingzhi Huang、Aiping Liu

  DOI：10.1002/jhet.4118

  日期：2020.11

  A series of novel pyridazinone derivatives were designed and synthesized by replacing 4‐(tert‐butyl)phenyl moiety of pyridaben with 2‐phenylthiazole or oxazole fragments via activity substructure connecting approach. The structures of all target compounds were characterized through NMR, MS, and elemental analysis. Bioassay results exhibit that most compounds showed potent bioactivities against Aphis

  通过活性亚结构连接方法，用2-苯基噻唑或恶唑片段取代了哒嗪的4-（叔丁基）苯基部分，设计并合成了一系列新型的哒嗪酮衍生物。所有目标化合物的结构均通过NMR，MS和元素分析表征。生物测定的结果表明，大多数化合物显示出对Fabs，Tetranychus urticae，Erysiphe graminis和/或Puccinia polysora的有效生物活性。在新合成的化合物中，2-（叔丁基）-4-氯5-（（（（2-苯基噻唑-4-基）甲基）硫基）哒嗪-3（2 H）-one（12b）对Fab表现出明显的杀虫活性。它的LC 50值（2.73 mg / L）比吡虫本（5.46 mg / L）好，尽管比吡虫啉（0.51 mg / L）低。除具有非凡的杀虫活性外，化合物12b在体内500 mg / L时对多聚磷也具有96.9％的杀真菌活性，显着优于吡达本（50.0％），但略低于戊唑醇（100％）。本文讨论
• Design, synthesis and Structure–activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
  作者：Zheng Li、Qianqian Qiu、Xue Xu、Xuekun Wang、Lei Jiao、Xin Su、Miaobo Pan、Wenlong Huang、Hai Qian

  DOI：10.1016/j.ejmech.2016.02.040

  日期：2016.5

  The free fatty acid receptor 1 (FFA1/GPR40) has attracted interest as a novel target for the treatment of type 2 diabetes. Several series of FFA1 agonists including TAK-875, the most advanced compound terminated in phase III studies due to concerns about liver toxicity, have been hampered by relatively high molecular weight and lipophilicity. Aiming to develop potent FFA1 agonists with low risk of

  游离脂肪酸受体1（FFA1 / GPR40）作为治疗2型糖尿病的新靶标已引起人们的关注。相对较高的分子量和亲脂性阻碍了包括FAK1激动剂在内的数个系列的FFA1激动剂（由于对肝毒性的担忧而在III期研究中终止的最先进的化合物）。为了通过降低亲脂性来开发具有低肝毒性风险的有效FFA1激动剂，TAK-875的中间苯基被11个极性五元杂芳族化合物所取代。随后，对SAR的系统探索和分子建模的应用导致了化合物44的鉴定，它是一种出色的FFA1激动剂，在正常和2型糖尿病小鼠中均具有强大的降血糖作用，即使在两倍摩尔的TAK-875剂量下也具有低血糖风险和肝毒性。同时，指出了两个重要发现。首先，我们的噻唑系列中的甲基占据了一个小的疏水亚口袋，与TAK-875没有相互作用。此外，激动活性显示与噻唑核心和末端苯环之间的二面角具有良好的相关性。这些结果促进了对配体结合口袋的了解，并可能有助于设计更有希望的FFA1激动剂。
• Design, synthesis and fungicidal activity evaluation of novel pyrimidinamine derivatives containing phenyl-thiazole/oxazole moiety
  作者：Zhongzhong Yan、Aiping Liu、Yingcan Ou、Jianming Li、Haibo Yi、Ning Zhang、Minhua Liu、Lu Huang、Jianwei Ren、Weidong Liu、Aixi Hu

  DOI：10.1016/j.bmc.2019.05.029

  日期：2019.8

  Diflumetorim is a member of pyrimidinamine fungicides that possess excellent antifungal activities. Nevertheless, as reported that the activity of diflumetorim to corn rust (Puccinia sorghi) was not ideal (EC50 = 53.26 mg/L). Herein, a series of novel pyrimidinamine derivatives containing phenyl-thiazole/oxazole moiety were designed based on our previous study and the structural characteristics of

  地氟美林是嘧啶胺杀菌剂的成员，具有优异的抗真菌活性。然而，据报道，双氟甲蝶呤对玉米锈病（高粱）的活性并不理想（EC50 = 53.26 mg / L）。在此，根据我们先前的研究和双氟甲草胺的结构特征，设计合成了一系列含有苯基-噻唑/恶唑部分的新型嘧啶胺衍生物，并对其进行了生物测定并进行了生物测定，以发现具有优异抗真菌活性的新型杀菌剂。在这些化合物中，T18具有最佳的杀真菌活性，分别对高粱P.orghi和E. graminis的EC50值为0.93 mg / L和1.24 mg / L，具有明显优于商业杀真菌剂diflumetorim，tebuconazole和flusilazole的防治效果。细胞的细胞毒性结果表明，化合物T18的毒性低于双氟甲蝶呤。此外，DFT计算表明，苯基噻唑/恶唑部分在活性提高中起着不可争辩的作用，这将有助于将来设计和开发更有效的化合物。
• [EN] TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE<br/>[FR] INHIBITEURS DE MYÉLOPEROXYDASE DE TYPE TRIAZOLOPYRIDINE ET TRIAZOLOPYRIMIDINE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2016040417A1

  公开（公告）日：2016-03-17

  The present invention provides compounds of Formula (I): wherein A and R1 are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.

  本发明提供了式（I）的化合物：其中A和R1如规范中所定义，并包括任何此类新化合物的组合物。这些化合物是髓过氧化物酶（MPO）抑制剂和/或嗜酸性粒细胞过氧化物酶（EPX）抑制剂，可用作药物。
• The Effect of Some 4,2 and 5,2 Bisthiazole Derivatives on Nitro-Oxidative Stress and Phagocytosis in Acute Experimental Inflammation
  作者：Cătălin Araniciu、Alina Pârvu、Mariana Palage、Smaranda Oniga、Daniela Benedec、Ilioara Oniga、Ovidiu Oniga

  DOI：10.3390/molecules19079240

  日期：——

  Nineteen bisthiazoles were tested in order to assess their anti-inflammatory and antioxidant properties. First, we evaluated the in vitro direct antioxidant capacity of the bisthiazoles using the DPPH radical scavenging method. Then, the anti-inflammatory effect was tested in acute rat experimental inflammation by measuring the acute phase bone marrow response, the phagocytic capacity and the serum nitro-oxidative stress status. Although none of the substances showed significant direct antioxidant potential in the DPPH assay, most of them improved serum oxidative status, when administered to rats with inflammation. Four of the bisthiazoles proved to have good anti-inflammatory properties, similar or superior to that of equal doses meloxicam.

  测试了19种双硫杂环烷以评估其抗炎和抗氧化特性。首先，我们使用DPPH自由基清除法评估了双硫杂环烷的体外直接抗氧化能力。然后，通过测量急性期骨髓反应、吞噬能力和血清氮-氧化应激状态，在急性大鼠实验性炎症中测试了其抗炎效果。尽管在DPPH实验中没有任何物质显示出明显的直接抗氧化潜力，但在给予患有炎症的大鼠时，大多数双硫杂环烷改善了血清氧化状态。其中四种双硫杂环烷显示出良好的抗炎特性，与同等剂量的美洛昔康相似或更优。